.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Baxter
Cipla
Dow
Novartis
Accenture
Mallinckrodt
US Army
Healthtrust

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,084,130

« Back to Dashboard

Which drugs does patent 7,084,130 protect, and when does it expire?


Patent 7,084,130 protects NAVSTEL and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 7,084,130

Title:Intraocular irrigating solution having improved flow characteristics
Abstract:Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Inventor(s): Shah; Mandar V. (Arlington, TX), Boukhny; Mikhail (Laguna Niguel, CA), Garner; William H. (Southlake, TX), Markwardt; Kerry L. (Mansfield, TX), Doshi; Uday (Randolph, NJ)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:10/240,449
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Alcon Pharms LtdNAVSTELcalcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphateSOLUTION;IRRIGATION022193-001Jul 24, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeYUSE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,084,130

PCT Information
PCT FiledDecember 11, 2001PCT Application Number:PCT/US01/48094
PCT Publication Date:June 27, 2002PCT Publication Number: WO02/49614

International Patent Family for Patent: 7,084,130

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil0116353► Subscribe
Canada2431368► Subscribe
Cyprus1110703► Subscribe
Spain2339745► Subscribe
Germany60141477► Subscribe
Denmark1343474► Subscribe
European Patent Office1343474► Subscribe
Hong Kong1055251► Subscribe
Japan2005502581► Subscribe
Japan2008308503► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Colorcon
Johnson and Johnson
AstraZeneca
Cerilliant
Federal Trade Commission
Express Scripts
UBS
Cantor Fitzgerald
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot